MA45579A - Systèmes et procédés de détermination de la sensibilité à l'insuline - Google Patents
Systèmes et procédés de détermination de la sensibilité à l'insulineInfo
- Publication number
- MA45579A MA45579A MA045579A MA45579A MA45579A MA 45579 A MA45579 A MA 45579A MA 045579 A MA045579 A MA 045579A MA 45579 A MA45579 A MA 45579A MA 45579 A MA45579 A MA 45579A
- Authority
- MA
- Morocco
- Prior art keywords
- insulin
- systems
- methods
- determining susceptibility
- susceptibility
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16178558 | 2016-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45579A true MA45579A (fr) | 2019-05-15 |
Family
ID=56409486
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045601A MA45601A (fr) | 2016-07-08 | 2017-06-22 | Systèmes et procédés de détermination de la sensibilité à l'insuline |
| MA045579A MA45579A (fr) | 2016-07-08 | 2017-06-22 | Systèmes et procédés de détermination de la sensibilité à l'insuline |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045601A MA45601A (fr) | 2016-07-08 | 2017-06-22 | Systèmes et procédés de détermination de la sensibilité à l'insuline |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11521730B2 (fr) |
| EP (2) | EP3482319B1 (fr) |
| JP (4) | JP7042791B2 (fr) |
| CN (2) | CN109661706B (fr) |
| MA (2) | MA45601A (fr) |
| WO (2) | WO2018007161A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA45601A (fr) | 2016-07-08 | 2019-05-15 | Novo Nordisk As | Systèmes et procédés de détermination de la sensibilité à l'insuline |
| FR3081316B1 (fr) | 2018-05-22 | 2022-12-09 | Commissariat Energie Atomique | Systeme automatise de controle de la glycemie d'un patient |
| WO2021042079A1 (fr) | 2019-08-30 | 2021-03-04 | TT1 Products, Inc. | Système d'entraînement physique à surveillance de biomarqueurs |
| JP2023502534A (ja) * | 2019-11-25 | 2023-01-24 | アボット ダイアベティス ケア インコーポレイテッド | 生理学的パラメータ分析のための方法、デバイス及びシステム |
| WO2021150442A1 (fr) * | 2020-01-23 | 2021-07-29 | Insulet Corporation | Détermination de l'insuline du repas pour une meilleure réponse post-prandiale |
| EP4165649A2 (fr) * | 2020-06-10 | 2023-04-19 | Bigfoot Biomedical, Inc. | Système de traitement du diabète en boucle fermée détectant un repas ou un bolus manqué |
| US11284818B2 (en) * | 2020-08-31 | 2022-03-29 | TT1 Products, Inc. | Glucose exposure diagnostics and therapeutics related thereto |
| USD1004777S1 (en) | 2021-09-01 | 2023-11-14 | TT1 Products, Inc. | Wrist reader |
| CN114145738B (zh) * | 2022-02-10 | 2022-06-24 | 苏州百孝医疗科技有限公司 | 分析物浓度数据生成方法和装置、监测分析物水平的系统 |
| US20230330336A1 (en) * | 2022-04-18 | 2023-10-19 | Luna Health, Inc. | Systems, devices and related methods of coordinating insulin management and delivery modes in fasting & non-fasting periods |
| CN119215262B (zh) * | 2023-06-30 | 2026-02-06 | 武汉联影智融医疗科技有限公司 | 针对胰岛素基础率的自动调整方法、装置和第一设备 |
| FR3162133A1 (fr) * | 2024-05-16 | 2025-11-21 | Diabeloop | Systèmes et procédés de régulation de la glycémie en boucle fermée |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2352295C (fr) * | 1998-11-30 | 2008-07-15 | Novo Nordisk A/S | Procede et systeme permettant a un utilisateur de s'administrer seul son traitement medical, ledit traitement medical comprenant plusieurs actes |
| US6544212B2 (en) | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
| US6883521B2 (en) | 2001-08-24 | 2005-04-26 | Dimensional Dosing Systems, Inc. | Method and apparatus for dosing single and multi-agent therapy |
| US6691043B2 (en) | 2001-08-28 | 2004-02-10 | Maxi-Med, Llc | Bolus calculator |
| US7404796B2 (en) | 2004-03-01 | 2008-07-29 | Becton Dickinson And Company | System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| US8282549B2 (en) * | 2003-12-09 | 2012-10-09 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
| JP4273036B2 (ja) * | 2004-05-12 | 2009-06-03 | 中 奥村 | 投薬支援プログラム、投薬支援装置、投薬支援プログラムを記録した記録媒体及び投薬支援システム |
| US20090036753A1 (en) | 2007-07-31 | 2009-02-05 | King Allen B | Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas |
| US20100262434A1 (en) | 2007-12-13 | 2010-10-14 | Shaya Steven A | Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose |
| CA2720304C (fr) | 2008-04-04 | 2018-05-15 | Hygieia, Inc. | Appareil pour optimiser un regime posologique d'insuline d'un patient |
| US9220456B2 (en) * | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
| US10624577B2 (en) * | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
| US8597570B2 (en) * | 2008-11-04 | 2013-12-03 | Panasonic Corporation | Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program |
| KR20110097889A (ko) * | 2008-12-23 | 2011-08-31 | 에프. 호프만-라 로슈 아게 | 수집 디바이스 상에서 구동하는 구조화된 수집 절차의 구현, 실행, 데이터 수집, 및 데이터 분석을 위한 관리 방법 및 시스템 |
| WO2011050337A1 (fr) | 2009-10-22 | 2011-04-28 | Abbott Diabetes Care Inc. | Procédés de modélisation des exigences de l'insulinothérapie |
| WO2012122520A1 (fr) | 2011-03-10 | 2012-09-13 | Abbott Diabetes Care Inc. | Dispositif de surveillance de substance à analyser à fonctions multiples et procédés d'utilisation |
| TW201333870A (zh) | 2011-12-21 | 2013-08-16 | 艾登工具股份有限公司 | 決定病人胰島素療法的系統及方法 |
| US10391242B2 (en) * | 2012-06-07 | 2019-08-27 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending bolus calculator adjustments |
| AU2015100005A4 (en) | 2014-01-27 | 2015-02-12 | Digital Medics Pty. Ltd. | Diabetic Connect Bluetooth Adaptor |
| US10456090B2 (en) * | 2014-11-22 | 2019-10-29 | Bigfoot Biomedical, Inc. | Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems |
| MA45601A (fr) | 2016-07-08 | 2019-05-15 | Novo Nordisk As | Systèmes et procédés de détermination de la sensibilité à l'insuline |
-
2017
- 2017-06-22 MA MA045601A patent/MA45601A/fr unknown
- 2017-06-22 US US16/315,766 patent/US11521730B2/en active Active
- 2017-06-22 JP JP2019500459A patent/JP7042791B2/ja active Active
- 2017-06-22 WO PCT/EP2017/065388 patent/WO2018007161A1/fr not_active Ceased
- 2017-06-22 WO PCT/EP2017/065378 patent/WO2018007160A1/fr not_active Ceased
- 2017-06-22 CN CN201780055381.5A patent/CN109661706B/zh active Active
- 2017-06-22 CN CN201780055289.9A patent/CN109690685B/zh active Active
- 2017-06-22 EP EP17743261.4A patent/EP3482319B1/fr active Active
- 2017-06-22 MA MA045579A patent/MA45579A/fr unknown
- 2017-06-22 JP JP2019500491A patent/JP7217698B2/ja active Active
- 2017-06-22 EP EP17731169.3A patent/EP3482314B1/fr active Active
- 2017-06-22 US US16/315,820 patent/US11195606B2/en active Active
-
2021
- 2021-12-03 JP JP2021196630A patent/JP2022043110A/ja not_active Withdrawn
- 2021-12-03 JP JP2021196701A patent/JP2022043112A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN109690685A (zh) | 2019-04-26 |
| JP2022043110A (ja) | 2022-03-15 |
| WO2018007160A1 (fr) | 2018-01-11 |
| EP3482314A1 (fr) | 2019-05-15 |
| US20190228853A1 (en) | 2019-07-25 |
| EP3482314B1 (fr) | 2020-11-18 |
| US11521730B2 (en) | 2022-12-06 |
| EP3482319B1 (fr) | 2020-12-09 |
| MA45601A (fr) | 2019-05-15 |
| EP3482319A1 (fr) | 2019-05-15 |
| US20190348164A1 (en) | 2019-11-14 |
| CN109661706A (zh) | 2019-04-19 |
| JP7217698B2 (ja) | 2023-02-03 |
| US11195606B2 (en) | 2021-12-07 |
| WO2018007161A1 (fr) | 2018-01-11 |
| JP2022043112A (ja) | 2022-03-15 |
| JP2019530914A (ja) | 2019-10-24 |
| JP2019530915A (ja) | 2019-10-24 |
| CN109690685B (zh) | 2023-09-08 |
| JP7042791B2 (ja) | 2022-03-28 |
| CN109661706B (zh) | 2023-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45601A (fr) | Systèmes et procédés de détermination de la sensibilité à l'insuline | |
| EP3399918A4 (fr) | Systèmes et procédés de détermination d'indications cliniques | |
| EP3545466A4 (fr) | Systèmes et procédés de détection d'objets dans des images | |
| EP3466031A4 (fr) | Systèmes et procédés de détection d'anomalie | |
| EP3529780A4 (fr) | Systèmes et procédés d'affichage d'images représentatives | |
| EP3513265A4 (fr) | Systèmes et procédés de détermination de quasi-collision | |
| EP2981623A4 (fr) | Systèmes et procédés d'évaluation de microbiomes et de traitement de ceux-ci | |
| EP3350979A4 (fr) | Systèmes et procédés destinés à la détection et l'évaluation des conducteurs distraits | |
| EP3408841A4 (fr) | Procédés et systèmes de détection de noyade | |
| EP3491820A4 (fr) | Procédés et systèmes de surveillance d'objet | |
| EP3469524A4 (fr) | Procédés et systèmes de calculs quantiques | |
| EP3512420A4 (fr) | Systèmes et procédés d'imagerie améliorés | |
| EP3371572A4 (fr) | Systèmes et procédés d'imagerie optogénétique | |
| EP3485237A4 (fr) | Systèmes et procédés de mesure de dose | |
| EP3542289A4 (fr) | Systèmes et procédés d'imagerie en temps réel | |
| EP3350578A4 (fr) | Systèmes et procédés d'imagerie couleur | |
| EP3285635A4 (fr) | Systèmes et procédés de détermination de distance par rapport à un objet | |
| EP2997531A4 (fr) | Procédés et systèmes de fourniture d'identifiants de paiement | |
| EP3509494A4 (fr) | Systèmes et procédés de détection d'infiltration iv | |
| EP3443749A4 (fr) | Systèmes et procédés d'affichage et de traitement de vidéo | |
| EP3402384A4 (fr) | Systèmes et procédés de détermination de la distance par rapport à un objet | |
| EP2916721A4 (fr) | Systèmes et procédés d'évaluation de neuropathologies | |
| EP3542299A4 (fr) | Systèmes et procédés de sécurisation d'accès à des ressources | |
| EP3328276A4 (fr) | Systèmes, appareil et procédés se rapportant à la modélisation, la surveillance et/ou la gestion du métabolisme | |
| EP3329456A4 (fr) | Procédés et systèmes de détermination de viabilité économique d'un microréseau |